Boryung Pharmaceutical Co., Ltd
Clinical trials sponsored by Boryung Pharmaceutical Co., Ltd, explained in plain language.
-
New study tracks Zepzelca's Real-World impact on tough lung cancer
Disease control Recruiting nowThis study observes how well the drug Zepzelca works and how safe it is for people with metastatic small cell lung cancer who have already tried platinum-based chemotherapy. About 300 participants will be followed in real-world clinics, not a lab. The goal is to see how many pati…
Sponsor: Boryung Pharmaceutical Co., Ltd • Aim: Disease control
Last updated May 26, 2026 02:23 UTC
-
New dosing strategy for schizophrenia drug under study
Disease control Recruiting nowThis study tests a different way of starting olanzapine in people with schizophrenia. The goal is to see if a slower dose increase is safer and still controls symptoms. About 120 adults who have had schizophrenia for over a year will take part. The study is currently recruiting.
Phase: PHASE2 • Sponsor: Boryung Pharmaceutical Co., Ltd • Aim: Disease control
Last updated May 26, 2026 02:20 UTC
-
New combo pill for high blood pressure under Real-World watch
Disease control Recruiting nowThis study is for adults with high blood pressure who are taking a single pill that combines two or three medicines (fimasartan/amlodipine with or without hydrochlorothiazide). The main goal is to see how well the pill controls blood pressure and what side effects occur over 12 w…
Sponsor: Boryung Pharmaceutical Co., Ltd • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
Diabetes drug switch could improve blood sugar control
Disease control Recruiting nowThis study tests whether changing from one diabetes medication combination to another can better control blood sugar in adults with type 2 diabetes. About 204 participants will either stay on their current drugs or switch to a new combination. The main goal is to see if the switc…
Phase: PHASE4 • Sponsor: Boryung Pharmaceutical Co., Ltd • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
New combo pill aims to simplify cholesterol treatment for thousands
Disease control Recruiting nowThis study looks at how well a single pill combining two cholesterol-lowering drugs (pitavastatin and ezetimibe) works in everyday medical practice. About 8,600 adults with high cholesterol or mixed lipid problems will take the pill and be followed to see if they reach their targ…
Sponsor: Boryung Pharmaceutical Co., Ltd • Aim: Disease control
Last updated May 20, 2026 11:56 UTC
-
New study tracks diabetes Drug's dual benefits for blood pressure
Disease control Recruiting nowThis study is observing how well the drug dapagliflozin works and how safe it is for people with type 2 diabetes who also have high blood pressure. Researchers will track blood sugar and blood pressure control in 9,000 participants over time. The goal is to see if this medication…
Sponsor: Boryung Pharmaceutical Co., Ltd • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
New chemo formula may reduce Alcohol-Like side effects in breast cancer patients
Symptom relief Recruiting nowThis study looks at whether a new version of the chemotherapy drug docetaxel, which does not contain ethanol (alcohol), causes fewer alcohol-like side effects in breast cancer patients. About 1,052 people receiving chemo before or after surgery will be observed. The goal is to se…
Sponsor: Boryung Pharmaceutical Co., Ltd • Aim: Symptom relief
Last updated May 20, 2026 11:53 UTC
-
Researchers watch, not treat: 1,000 patients tracked after cancer therapy fails
Knowledge-focused Recruiting nowThis study follows 1,000 people with metastatic colorectal cancer whose first chemotherapy stopped working. Researchers will record which second or later treatments doctors choose and how long patients live or stay cancer-free. No new drug is tested; the goal is to learn from rea…
Sponsor: Boryung Pharmaceutical Co., Ltd • Aim: Knowledge-focused
Last updated May 26, 2026 02:22 UTC
-
3,000 bipolar patients tracked to see if Weight-Gain warnings actually work
Knowledge-focused Recruiting nowThis study follows 3,000 people with bipolar disorder who are taking olanzapine. Researchers want to see what other medicines they use and whether teaching them about weight gain helps prevent it. No new drug is being tested—just observing real-world treatment patterns.
Sponsor: Boryung Pharmaceutical Co., Ltd • Aim: Knowledge-focused
Last updated May 26, 2026 02:15 UTC